Pathophysiology of chronic venous disease

Area of Science:

• Vascular Biology
• Pathophysiology
• Medical Science

Background:

• Chronic venous disease (CVD) affects 60-70% of the population, presenting with visible veins, pain, swelling, and potentially leading to venous ulceration.
• The core issue in CVD is venous hypertension, which triggers inflammation and activates complex molecular pathways.
• Genetic and environmental factors contribute to CVD development, impacting venous wall integrity and extracellular matrix.

Purpose of the Study:

• To elucidate the complex pathophysiology of chronic venous disease.
• To highlight the role of inflammation secondary to venous hypertension in CVD progression.
• To identify key molecular and cellular mechanisms involved in CVD, including endothelial and leukocyte interactions.

Main Methods:

• Review of existing literature on CVD pathophysiology.
• Analysis of inflammatory pathways, including cytokines, chemokines, and proteases.
• Examination of the roles of the endothelium, glycocalyx, and leukocyte transmigration.

Main Results:

• Venous hypertension leads to endothelial activation and leukocyte recruitment, causing venous wall injury.
• Activated leukocytes release inflammatory mediators that promote persistent inflammation and tissue damage.
• Alterations in protein structure and extracellular matrix contribute to the progressive nature of CVD.

Conclusions:

• Understanding the interplay of inflammation, cellular changes, and structural alterations is key to managing CVD.
• Future research focusing on metabolic changes, miRNA regulation, and inflammatory modulation is essential.
• Investigating the glycocalyx offers potential for novel therapeutic strategies in CVD treatment and prevention.